Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug;27(4):540-549.
doi: 10.1007/s11307-025-02028-x. Epub 2025 Jun 24.

Diagnostic Value of [18F]-FDG and [68 Ga]-FAPI-04 PET/MRI for Lymph Node Metastasis in Papillary Thyroid Cancer

Affiliations

Diagnostic Value of [18F]-FDG and [68 Ga]-FAPI-04 PET/MRI for Lymph Node Metastasis in Papillary Thyroid Cancer

Tingting Han et al. Mol Imaging Biol. 2025 Aug.

Abstract

Purpose: This study aimed to evaluate the diagnostic value of [18F]-FDG PET/MRI for the diagnosis of neck lymph node metastasis (LNM) in patients with initially diagnosed papillary thyroid cancer (PTC) and to compare it with [68 Ga]-FAPI-04 PET/MRI.

Methods: Thirty patients with PTC confirmed by thyroid fine-needle aspiration biopsy were prospectively enrolled and underwent [18F]-FDG PET/MRI; of which, 6 additionally underwent [68 Ga]-FAPI-04 PET/MRI within 3 days. According to surgical guidelines, the neck lymph node (LN) was divided into three macroscopic regions: central (VI) and left/right lateral neck (II-V). Images were semi-quantitatively and visually interpreted, and lesions' quantity, location, and uptake values were noted. Diagnostic performance of [18F]-FDG PET/MRI versus US and MRI in N-staging of PTC patients based on regional analysis using postoperative histopathology as the gold standard. Whether the BRAFV600E mutation or not affects metastatic LN radioactivity uptake. Exploring the relevance of dual tracer imaging of metastatic LN radioactivity uptake and its head-to-head comparison for diagnostic efficacy.

Results: A total of 48 macroscopic regions were surgically dissected. In terms of predicting LNM, the diagnostic efficacy of [18F]-FDG PET/MRI for detecting LNM was higher than that of US and MRI, overall sensitivity, specificity, and accuracy were 71.1% vs. 60.5% vs. 65.8%, 90.0% vs.80.0% vs. 80.0%, and 75.0% vs. 64.6% vs. 68.8%, respectively (all P > 0.05). SUVmax of metastatic LNs on [68 Ga]-FAPI-04 PET/MRI was positively correlated with [18F]-FDG PET/MRI (r = 0.8564, 95%CI: 0.7208-0.9289; P < 0.0001). BRAFV600E mutation had no significant effect on the [18F]-FDG uptake level and TBR value in metastatic LN of PTC (SUVmax: 2.5 ± 2.3 vs. 2.2 ± 1.1; TBR: 2.9 ± 2.6 vs. 2.6 ± 1.4; all P > 0.05). The positive lesion detection rate of dual tracer imaging in 6 patients with PTC is consistent, and the degree of radioactivity uptake of [68 Ga]-FAPI-04 was higher than that of [18F]-FDG in both primary lesion and LNM (12.3 ± 5.7 vs. 6.9 ± 5.3;4.5 ± 3.7 vs. 3.4 ± 1.8; all P > 0.05).

Conclusion: [1⁸F]-FDG PET/MRI demonstrated marginally superior diagnostic performance for LNM detection compared to US and MRI, but all three modalities exhibited suboptimal sensitivity, particularly in the central region. Small sample populations revealed no significant differences in [68 Ga]-FAPI-04 and [18F]-FDG uptake levels in primary lesion and LNM of PTC, but relatively lower nonspecific uptake of [68 Ga]-FAPI-04 pharyngeal lymphatic ring may have the potential to reduce diagnostic error in specific diseases.

Keywords: Lymph node metastasis; PET/MRI; Papillary thyroid cancer; [18F]-FDG; [68 Ga]-FAPI-04.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethical Approval: This study was performed in line with the principles of the Declaration of Helsinki. The study received ethical approval from the independent ethics committee of Xijng Hospital (Approval No. KY20212145-F-1). Consent to Participate: Informed consent was obtained from all patients. Competing Interests: The authors declare that they have no conflict of interest.

Similar articles

References

    1. Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics, 2024. CA Cancer J Clin 74:12–49 - PubMed
    1. Park CH, Song CM, Ji YB et al (2015) Significance of the extracapsular spread of metastatic lymph nodes in papillary thyroid carcinoma. Clin Exp Otorhinolaryngol 8:289–294 - PubMed - PMC
    1. Miranda-Filho A, Lortet-Tieulent J, Bray F et al (2021) Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes Endocrinol 9:225–234 - PubMed
    1. Lai SW, Fan YL, Zhu YH et al (2022) Machine learning-based dynamic prediction of lateral lymph node metastasis in patients with papillary thyroid cancer. Front Endocrinol (Lausanne) 13:1019037 - PubMed
    1. Xing Z, Qiu Y, Yang Q et al (2020) Thyroid cancer neck lymph nodes metastasis: Meta-analysis of US and CT diagnosis. Eur J Radiol 129:109103 - PubMed

LinkOut - more resources